The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
Open accessAbstract
BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly recognized cause of illness in adults. Data on the epidemiology and clinical effects in community-dwelling elderly persons and high-risk adults can help in assessing the need for vaccine development. METHODS: During four consecutive winters, we evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (> or =65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions. RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serologic studies. RESULTS: A total of 608 healthy elderly patients and 540 high-risk adults were enrolled in prospective surveillance, and 1388 hospitalized patients were enrolled. A total of 2514 illnesses were evaluated. RSV infection was identified in 102 patients in the prospective cohorts and 142 hospitalized patients, and influenza A was diagnosed in 44 patients in the prospective cohorts and 154 hospitalized patients. RSV infection developed annually in 3 to 7 percent of healthy elderly patients and in 4 to 10 percent of high-risk adults. Among healthy elderly patients, RSV infection generated fewer office visits than influenza; however, the use of health care services by high-risk adults was similar in the two groups. In the hospitalized cohort, RSV infection and influenza A resulted in similar lengths of stay, rates of use of intensive care (15 percent and 12 percent, respectively), and mortality (8 percent and 7 percent, respectively). On the basis of the diagnostic codes of the International Classification of Diseases, 9th Revision, Clinical Modification at discharge, RSV infection accounted for 10.6 percent of hospitalizations for pneumonia, 11.4 percent for chronic obstructive pulmonary disease, 5.4 percent for congestive heart failure, and 7.2 percent for asthma. CONCLUSIONS: RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high. An effective RSV vaccine may offer benefits for these adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,748
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Katz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421
Respiratory Syncytial Virus and Parainfluenza Virus
Hall, C. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442507 · Cited by 1,233
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children
Williams, J. V., Harris, P. A., Tollefson, S. J., Halburnt-Rush, L. L., Pingsterhaus, J. M., Edwards, K. M., Wright, P. F., & Crowe, J. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa025472 · Cited by 991
Dowell, S. F., Anderson, L. J., Gary, H. E., Erdman, D. D., Plouffe, J. F., File, T. M., Marston, B. J., & Breiman, R. F. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.456 · Cited by 413
Nicholson, K. G., Kent, J., Hammersley, V., & Cancio, E. (1997) · BMJ · doi:10.1136/bmj.315.7115.1060 · Cited by 381
Zambon, M., Stockton, J., Clewley, J., & Fleming, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06528-x · Cited by 378
Respiratory Syncytial Virus and Influenza A Infections in the Hospitalized Elderly
Falsey, A. R., Cunningham, C. K., Barker, W. H., Kouides, R. W., Yuen, J. B., Menegus, M., Weiner, L. B., Bonville, C. A., & Betts, R. F. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.389 · Cited by 371
Self-citation
Research works printed but not linked: 7
- 10.1056/NEJM196207122670204 · doi:10.1056/nejm196207122670204
- 10.1016/S0163-4453(84)94075-1 · doi:10.1016/s0163-4453(84)94075-1
- 10.1016/S0163-4453(84)90530-9 · doi:10.1016/s0163-4453(84)90530-9
- 10.1136/bmj.287.6405.1618 · doi:10.1136/bmj.287.6405.1618
- 10.1164/ajrccm/136.3.561 · doi:10.1164/ajrccm/136.3.561
- 10.1016/S0140-6736(01)06488-1 · doi:10.1016/s0140-6736(01)06488-1
- 10.1002/1096-9071(200103)63:3<259::AID-JMV1010>3.0.CO;2-X · doi:10.1002/1096-9071(200103)63:3<259::aid-jmv1010>3.0.co;2-x
Cited by
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sethi, S., & Murphy, T. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800353 · Cited by 1,234
Ruuskanen, O., Lahti, E., Jennings, L. C., & Murdoch, D. R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61459-6 · Cited by 1,124
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Papi, A., Ison, M. G., Langley, J. M., Lee, D.-G., Leroux-Roels, I., Martinon-Torres, F., Schwarz, T. F., van Zyl-Smit, R. N., Campora, L., Dezutter, N., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2209604 · Cited by 774
Activation of innate immune antiviral responses by Nod2
Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P. H., Xiang, Y., & Bose, S. (2009) · Nature Immunology · doi:10.1038/ni.1782 · Cited by 751
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Walsh, E. E., Pérez Marc, G., Zareba, A. M., Falsey, A. R., Jiang, Q., Patton, M., Polack, F. P., Llapur, C., Doreski, P. A., Ilangovan, K., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213836 · Cited by 668
Self-citationRespiratory Syncytial Virus—A Comprehensive Review
Borchers, A. T., Chang, C., Gershwin, M. E., & Gershwin, L. J. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8368-9 · Cited by 645
Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells
Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., & Bieniasz, P. D. (2009) · Cell · doi:10.1016/j.cell.2009.08.039 · Cited by 595
Kushnir, N., Streatfield, S. J., & Yusibov, V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 587
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
Khan, M., Adil, S. F., Alkhathlan, H. Z., Tahir, M. N., Saif, S., Khan, M., & Khan, S. T. (2020) · Molecules · doi:10.3390/molecules26010039 · Cited by 584
Zhou, H., Thompson, W. W., Viboud, C. G., Ringholz, C. M., Cheng, P.-Y., Steiner, C., Abedi, G. R., Anderson, L. J., Brammer, L., & Shay, D. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis211 · Cited by 573
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Asthma Exacerbations: Pathogenesis, Prevention, and Treatment
Castillo, J. R., Peters, S. P., & Busse, W. W. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.05.001 · Cited by 544
Li, Y., Reeves, R. M., Wang, X., Bassat, Q., Brooks, W. A., Cohen, C., Moore, D. P., Nunes, M., Rath, B., Campbell, H., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30264-5 · Cited by 539
Shi, T., Denouel, A., Tietjen, A. K., Campbell, I., Moran, E., Li, X., Campbell, H., Demont, C., Nyawanda, B. O., Chu, H. Y., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz059 · Cited by 526
Self-citationMortality benefits of influenza vaccination in elderly people: an ongoing controversy
Simonsen, L., Taylor, R. J., Viboud, C., Miller, M. A., & Jackson, L. A. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70236-0 · Cited by 520
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Wilson, E., Goswami, J., Baqui, A. H., Doreski, P. A., Perez-Marc, G., Zaman, K., Monroy, J., Duncan, C. J. A., Ujiie, M., Rämet, M., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307079 · Cited by 500
Self-citationViral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis
Collins, P. L., & Graham, B. S. (2008) · Journal of Virology · doi:10.1128/jvi.01625-07 · Cited by 486
Mazur, N. I., Higgins, D., Nunes, M. C., Melero, J. A., Langedijk, A. C., Horsley, N., Buchholz, U. J., Openshaw, P. J., McLellan, J. S., Englund, J. A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30292-5 · Cited by 457
Self-citationCollins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
DeVincenzo, J., Lambkin-Williams, R., Wilkinson, T., Cehelsky, J., Nochur, S., Walsh, E., Meyers, R., Gollob, J., & Vaishnaw, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 442
Self-citationCOPD exacerbations {middle dot} 2: Aetiology
Sapey, E. (2006) · Thorax · doi:10.1136/thx.2005.041822 · Cited by 437
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & De Gregorio, E. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 435
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Ngwuta, J. O., Chen, M., Modjarrad, K., Joyce, M. G., Kanekiyo, M., Kumar, A., Yassine, H. M., Moin, S. M., Killikelly, A. M., Chuang, G.-Y., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4241 · Cited by 431
Fry, A. M. (2005) · JAMA · doi:10.1001/jama.294.21.2712 · Cited by 425
Zaas, A. K., Chen, M., Varkey, J., Veldman, T., Hero, A. O., Lucas, J., Huang, Y., Turner, R., Gilbert, A., Lambkin-Williams, R., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.07.006 · Cited by 421
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Mazur, N. I., Terstappen, J., Baral, R., Bardají, A., Beutels, P., Buchholz, U. J., Cohen, C., Crowe, J. E., Cutland, C. L., Eckert, L., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00291-2 · Cited by 420
Savic, M., Penders, Y., Shi, T., Branche, A., & Pirçon, J. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13031 · Cited by 414
Respiratory syncytial virus entry and how to block it
Battles, M. B., & McLellan, J. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0149-x · Cited by 402
Ackerson, B., Tseng, H. F., Sy, L. S., Solano, Z., Slezak, J., Luo, Y., Fischetti, C. A., & Shinde, V. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy991 · Cited by 391
Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection
Horne, B. D., Joy, E. A., Hofmann, M. G., Gesteland, P. H., Cannon, J. B., Lefler, J. S., Blagev, D. P., Korgenski, E. K., Torosyan, N., Hansen, G. I., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1883oc · Cited by 390
Imaging of Pulmonary Viral Pneumonia
Franquet, T. (2011) · Radiology · doi:10.1148/radiol.11092149 · Cited by 380
The CD8 T Cell Response to Respiratory Virus Infections
Schmidt, M. E., & Varga, S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00678 · Cited by 371
“Lancet Infect Dis (2009) 9(5):291–300.”
Chang, J. S., Wang, K. C., Yeh, C. F., Shieh, D. E., & Chiang, L. C. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.043 · Cited by 369
Widmer, K., Zhu, Y., Williams, J. V., Griffin, M. R., Edwards, K. M., & Talbot, H. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis309 · Cited by 364
High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
Lee, N., Lui, G. C. Y., Wong, K. T., Li, T. C. M., Tse, E. C. M., Chan, J. Y. C., Yu, J., Wong, S. S. M., Choi, K. W., Wong, R. Y. K., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit471 · Cited by 360
The role of vaccines in preventing bacterial antimicrobial resistance
Jansen, K. U., Knirsch, C., & Anderson, A. S. (2018) · Nature Medicine · doi:10.1038/nm.4465 · Cited by 355
Stockman, L. J., Curns, A. T., Anderson, L. J., & Fischer-Langley, G. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822e68e6 · Cited by 352
Asthma exacerbations: Origin, effect, and prevention
Jackson, D. J., Sykes, A., Mallia, P., & Johnston, S. L. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.024 · Cited by 343
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
Eden, J.-S., Sikazwe, C., Xie, R., Deng, Y.-M., Sullivan, S. G., Michie, A., Levy, A., Cutmore, E., Blyth, C. C., Britton, P. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30485-3 · Cited by 340
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
DeVincenzo, J. P., Whitley, R. J., Mackman, R. L., Scaglioni-Weinlich, C., Harrison, L., Farrell, E., McBride, S., Lambkin-Williams, R., Jordan, R., Xin, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401184 · Cited by 339
Respiratory syncytial virus infection in adults
Nam, H. H., & Ison, M. G. (2019) · BMJ · doi:10.1136/bmj.l5021 · Cited by 332
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
DeVincenzo, J. P., Wilkinson, T., Vaishnaw, A., Cehelsky, J., Meyers, R., Nochur, S., Harrison, L., Meeking, P., Mann, A., Moane, E., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0221oc · Cited by 330
Self-citationWang, Q., Lee, I., Ren, J., Ajay, S. S., Lee, Y. S., & Bao, X. (2013) · Molecular Therapy · doi:10.1038/mt.2012.237 · Cited by 304
High, K. P., Bradley, S. F., Gravenstein, S., Mehr, D. R., Quagliarello, V. J., Richards, C., & Yoshikawa, T. T. (2009) · Clinical Infectious Diseases · doi:10.1086/595683 · Cited by 302
Falsey, A. R., McElhaney, J. E., Beran, J., van Essen, G. A., Duval, X., Esen, M., Galtier, F., Gervais, P., Hwang, S.-J., Kremsner, P., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit839 · Cited by 299
Self-citationViruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic review
Papadopoulos, N. G., Christodoulou, I., Rohde, G., Agache, I., Almqvist, C., Bruno, A., Bonini, S., Bont, L., Bossios, A., Bousquet, J., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02505.x · Cited by 288
Seasonal Incidence of Symptomatic Influenza in the United States
Tokars, J. I., Olsen, S. J., & Reed, C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1060 · Cited by 288
Habibi, M. S., Jozwik, A., Makris, S., Dunning, J., Paras, A., DeVincenzo, J. P., de Haan, C. A. M., Wrammert, J., Openshaw, P. J. M., & Chiu, C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2256oc · Cited by 287
Airway Mucus: From Production to Secretion
Williams, O. W., Sharafkhaneh, A., Kim, V., Dickey, B. F., & Evans, C. M. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0436sf · Cited by 284
RNAi‐based therapeutics–current status, challenges and prospects
Tiemann, K., & Rossi, J. J. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900023 · Cited by 283
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Corti, D., Bianchi, S., Vanzetta, F., Minola, A., Perez, L., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B. J., et al. (2013) · Nature · doi:10.1038/nature12442 · Cited by 278
Magro, M., Mas, V., Chappell, K., Vázquez, M., Cano, O., Luque, D., Terrón, M. C., Melero, J. A., & Palomo, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115941109 · Cited by 271
“H respiratory syncytial virus (hRSV) is the most important viral cause of severe respiratory tract disease in the pediatric population worldwide (1) and is also of considerable importance in the elderly and immunocompromised adults (2).”
BackgroundMethodHanania, N. A., King, M. J., Braman, S. S., Saltoun, C., Wise, R. A., Enright, P., Falsey, A. R., Mathur, S. K., Ramsdell, J. W., Rogers, L., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.048 · Cited by 263
Self-citationChartrand, C., Tremblay, N., Renaud, C., & Papenburg, J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01816-15 · Cited by 262
Human Metapneumovirus Infections in Adults: Another Piece of the Puzzle
Walsh, E. E., Peterson, D. R., & Falsey, A. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2489 · Cited by 254
Self-citationKrishnamoorthy, N., Khare, A., Oriss, T. B., Raundhal, M., Morse, C., Yarlagadda, M., Wenzel, S. E., Moore, M. L., Peebles, R. S., Ray, A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2896 · Cited by 241
Graham, B. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00972.x · Cited by 239
McElhaney, J. E., Zhou, X., Talbot, H. K., Soethout, E., Bleackley, R. C., Granville, D. J., & Pawelec, G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.015 · Cited by 229
Min, D., Panoskaltsis-Mortari, A., Kuro-o, M., Holländer, G. A., Blazar, B. R., & Weinberg, K. I. (2007) · Blood · doi:10.1182/blood-2006-08-043794 · Cited by 214
“An example of the severity of this problem is the recent description of as many as 170,000 hospitalizations and 14,000 deaths per year in the United States among elderly patients infected with respiratory syncytial virus, a pathogen usually thought of as a childhood illness.(69) While immunization is a logical approac…”
Espeseth, A. S., Cejas, P. J., Citron, M. P., Wang, D., DiStefano, D. J., Callahan, C., Donnell, G. O., Galli, J. D., Swoyer, R., Touch, S., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0163-z · Cited by 190
Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
Ruckwardt, T. J., Morabito, K. M., & Graham, B. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.007 · Cited by 185
Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation
Falsey, A. R., Becker, K. L., Swinburne, A. J., Nylen, E. S., Formica, M. A., Hennessey, P. A., Criddle, M. M., Peterson, D. R., Baran, A., & Walsh, E. E. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit190 · Cited by 159
“bacterial pneumonia and seasonal viral respiratory tract infection have been reported, there are few specific data on the risk of bacterial complications of seasonal influenza and other virus infections [1, 10, 11].”
BackgroundSelf-citationInnate immune responses in the ageing lung.
Boe, D. M., Boule, L. A., & Kovacs, E. J. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12881 · Cited by 156
Low zinc status: a new risk factor for pneumonia in the elderly?
Barnett, J. B., Hamer, D. H., & Meydani, S. N. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00253.x · Cited by 149
Aliprantis, A. O., Shaw, C. A., Griffin, P., Farinola, N., Railkar, R. A., Cao, X., Liu, W., Sachs, J. R., Swenson, C. J., Lee, H., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1829899 · Cited by 149
Wang, H., Peters, N., & Schwarze, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6263 · Cited by 149
Local heroes or villains: tissue-resident memory T cells in human health and disease
Sasson, S. C., Gordon, C. L., Christo, S. N., Klenerman, P., & Mackay, L. K. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0359-1 · Cited by 111
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations
De Serres, G., Lampron, N., La Forge, J., Rouleau, I., Bourbeau, J., Weiss, K., Barret, B., & Boivin, G. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.07.010 · Cited by 108
Bondue, B., Vosters, O., de Nadai, P., Glineur, S., De Henau, O., Luangsay, S., Van Gool, F., Communi, D., De Vuyst, P., Desmecht, D., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002358 · Cited by 92
Feikin, D. R., Abu-Raddad, L. J., Andrews, N., Davies, M.-A., Higdon, M. M., Orenstein, W. A., & Patel, M. K. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.04.069 · Cited by 83
Reed, M., Morris, S. H., Owczarczyk, A. B., & Lukacs, N. W. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.3 · Cited by 85
Ahmed-Hassan, H., Sisson, B., Shukla, R. K., Wijewantha, Y., Funderburg, N. T., Li, Z., Hayes, D., Demberg, T., & Liyanage, N. P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01979 · Cited by 47
Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
Rossey, I., & Saelens, X. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1675520 · Cited by 32
Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review
Gavaruzzi, T., Ceccarelli, A., Nanni, C., Vignali, C., Colonnello, V., Caserotti, M., Riccò, M., & Gori, D. (2025) · Vaccines · doi:10.3390/vaccines13020159 · Cited by 29
Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes
Fedechkin, S. O., George, N. L., Nuñez Castrejon, A. M., Dillen, J. R., Kauvar, L. M., & DuBois, R. M. (2020) · Journal of Virology · doi:10.1128/jvi.01879-19 · Cited by 26
Ritz, T., Salsman, M. L., Young, D. A., Lippert, A. R., Khan, D. A., & Ginty, A. T. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100255 · Cited by 17
Metadata
- Authors
- Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-28
- Volume
- 352
- Issue
- 17
- Pages
- 1749-1759
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1989501142
- Cited by
- 2,226
- References
- 28
- FWCI
- 45.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.